MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    Associations between subjective and objective cognitive decline in Parkinson’s disease

    K. Mills, R. Schneider, D. Oaks, M. Saint-Hilaire, R. Hauser, A. Lange, K. Blindauer, M. Halverson, G. Ross, I. Litvan, S. Eberly, T. Simuni, C. Marras (Baltimore, MD, USA)

    Objective: To evaluate associations between objective and subjective cognitive function over time in Parkinson’s disease (PD) using data from a clinical trial that enrolled patients…
  • MDS Virtual Congress 2020

    Anticholinergic Use in Parkinson’s Disease: Practice Patterns in Patients with Cognitive Impairment

    N. Shetty, O. Dubaz, Y. Yu, H. Gao, T. Simuni (Chicago, IL, USA)

    Objective: To explore utilization of anticholinergic medications using the Parkinson Foundation Quality Improvement Initiative (PF-QII) registry. Background: Recent publications have highlighted the association between anticholinergic…
  • MDS Virtual Congress 2020

    Cerebral microvascular injury provoked by alpha-synuclein preformed fibrils exacerbates cognitive dysfunction in Parkinson’s disease

    Q.X Zhang, Y.Y Gao, L.J Wang (Guangzhou, China)

    Objective: The aim of this study was to investigate the role of microvascular pathology between abnormal αSyn aggregation and PD cognitive dysfunction. Background: Higher plasma…
  • MDS Virtual Congress 2020

    Northwestern University Feinberg School of Medicine Parkinson’s disease and Movement Disorders Center Biorepository: bringing the clinic and lab together

    A. Hernandez, S. Lubbe, T. Simuni, D. Bega, D. Krainc, N. Mencacci, R. Modiest, P. Opal, C. Taylor, N. Shetty, R. Malkani, J. Blackburn (Chicago, IL, USA)

    Objective: To establish a biobank of DNA and tissue samples from a population of movement disorder patients, their family members and healthy controls recruited from…
  • MDS Virtual Congress 2020

    Association between SNCA and clinical phenotypes of Parkinson’s disease in southern Chinese

    G. Li, SS. Cui, P. Huang, S.D Chen, YY. Tan (Shanghai, China)

    Objective: The aim was to investigate the association between SNCA and clinical phenotypes of Parkinson’s disease (PD) in southern Chinese. Background: SNCA gene plays an…
  • MDS Virtual Congress 2020

    Sensitive biomarker of Parkinson’s disease linked to mutations in the glucocerebrosidase gene

    S. Pchelina, M. Nikolaev, A. Kopytova, G. Baydakova, K. Senkevich, I. Miliukhina, T. Usenko, A. Emelyanov, E. Zakharova (St.Petersburg, Russian Federation)

    Objective: To find a biomarker for development of Parkinson’s disease (PD) in carriers of mutations in the glucocerebrosidase gene (GBA). Background: Mutations in the GBA…
  • MDS Virtual Congress 2020

    Utility of multigene panel testing for diagnosing parkinsonism and dystonia in a large cohort of >500 patients

    H. Zghal Elloumi, M. Stosser, A. Lindy (Gaithersburg, MD, USA)

    Objective: Evaluate the utility of multigene Next-Generation Sequencing (NGS) for molecular diagnosis of parkinsonism and dystonia. Background: Parkinson's disease (PD) and dystonia are common neurodegenerative…
  • MDS Virtual Congress 2020

    Screening of mutations in PARK2 gene and Dopamine levels in Parkinson’s disease (PD) patients in Coimbatore population, India

    I. Iyer, V. Venkatesan, V. Vellingiri (Coimbatore, India)

    Objective: The aim of the present study was to perform the mutational screening of PARK2 gene and dopamine level in PD patients of Coimbatore population,…
  • MDS Virtual Congress 2020

    α-Synuclein propagation via olfactory pathway induces olfactory bulb atrophy and widespread glucose hypometabolism in a non-human primate model

    M. Sawamura, H. Onoe, H. Tsukada, K. Isa, N. Uemura, T. Isa, R. Takahashi (Kyoto, Japan)

    Objective: We investigated how α-synuclein (α-Syn) pathology spreads from the olfactory bulb (OB) and how the pathology affects brain structure and activity. Background: Parkinson's disease…
  • MDS Virtual Congress 2020

    Identifying the functional brain network of motor reserve in early Parkinson’s disease

    S.J Chung, H.R Kim, J.H Jung, P.H Lee, Y. Jeong, Y.H Sohn (Seoul, Republic of Korea)

    Objective: To explore the functional brain network associated with motor reserve in early-stage Parkinson’s disease (PD). Background: The severity of motor symptoms in PD does…
  • « Previous Page
  • 1
  • …
  • 125
  • 126
  • 127
  • 128
  • 129
  • …
  • 149
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley